PDL BioPharma Inc. (PDLI)

3.15
0.01 0.47
NASDAQ : Health Technology
Prev Close 3.17
Open 3.16
Day Low/High 3.13 / 3.19
52 Wk Low/High 2.25 / 3.89
Volume 262.57K
Avg Volume 1.14M
Exchange NASDAQ
Shares Outstanding 119.65M
Market Cap 373.30M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
PDL BioPharma Named Top 10 Dividend Stock With 16.63% Yield (PDLI)

PDL BioPharma Named Top 10 Dividend Stock With 16.63% Yield (PDLI)

PDL BioPharma Inc has been named as a Top 10 dividend stock, according the most recent Dividend Channel ''DividendRank'' report. The report noted that among the coverage universe, PDLI shares displayed both attractive valuation metrics and strong profitability metrics.

PDL BioPharma Named Top Dividend Stock With Insider Buying and 15.88% Yield (PDLI)

PDL BioPharma Named Top Dividend Stock With Insider Buying and 15.88% Yield (PDLI)

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: PDLI, KNX, AME

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: PDLI, KNX, AME

PDLI KNX AME are going ex-dividend tomorrow, Wednesday, December 02, 2015

Cash Dividend On The Way From PDL BioPharma (PDLI)

Cash Dividend On The Way From PDL BioPharma (PDLI)

Looking at the universe of stocks we cover at Dividend Channel, on 12/2/15, PDL BioPharma Inc will trade ex-dividend, for its quarterly dividend of $0.15, payable on 12/11/15. As a percentage of PDLI's recent stock price of $3.83, this dividend works out to approximately 3.91%, so look for shares of PDL BioPharma Inc to trade 3.91% lower — all else being equal — when PDLI shares open for trading on 12/2/15.

3 Hold-Rated Dividend Stocks: RGC, PDLI, CVX

3 Hold-Rated Dividend Stocks: RGC, PDLI, CVX

These 3 dividend stocks are rated a Hold by TheStreet

The 10 Highest Dividend Health Care Stocks Are Not All Buys

The 10 Highest Dividend Health Care Stocks Are Not All Buys

Health care stocks have been among the strongest performers to date, but investors shouldn't automatically buy into stocks with the highest dividends yields.

3 Hold-Rated Dividend Stocks: ENLK, MAT, PDLI

3 Hold-Rated Dividend Stocks: ENLK, MAT, PDLI

These 3 dividend stocks are rated a Hold by TheStreet

RSI Alert: PDL BioPharma (PDLI) Now Oversold

RSI Alert: PDL BioPharma (PDLI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of PDLI May 2016 Options Trading

First Week of PDLI May 2016 Options Trading

Investors in PDL BioPharma Inc saw new options begin trading this week, for the May 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

3 Hold-Rated Dividend Stocks: PDLI, CY, CLNY

3 Hold-Rated Dividend Stocks: PDLI, CY, CLNY

These 3 dividend stocks are rated a Hold by TheStreet

PDL BioPharma Named Top Dividend Stock With Insider Buying and 11.09% Yield (PDLI)

PDL BioPharma Named Top Dividend Stock With Insider Buying and 11.09% Yield (PDLI)

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

PDL BioPharma (PDLI) Highlighted As Weak On High Volume

PDL BioPharma (PDLI) Highlighted As Weak On High Volume

Trade-Ideas LLC identified PDL BioPharma (PDLI) as a weak on high relative volume candidate

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: ROYT, PDLI, CBOE

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: ROYT, PDLI, CBOE

ROYT PDLI CBOE are going ex-dividend tomorrow, Wednesday, September 02, 2015

Top Buys by Top Brass: Vice President, CFO Garcia's $116.5K Bet on PDLI

Top Buys by Top Brass: Vice President, CFO Garcia's $116.5K Bet on PDLI

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

Snatch This Bargain 10.3% Yielder Even Cheaper Than Vice President, CFO Garcia Did

Snatch This Bargain 10.3% Yielder Even Cheaper Than Vice President, CFO Garcia Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 14, PDL BioPharma Inc's Vice President, CFO, Peter S.

PDLI Dividend Yield Pushes Above 10%

PDLI Dividend Yield Pushes Above 10%

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of PDL BioPharma Inc were yielding above the 10% mark based on its quarterly dividend (annualized to $0.60), with the stock changing hands as low as $5.95 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return.

Relative Strength Alert For PDL BioPharma

Relative Strength Alert For PDL BioPharma

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. PDL BioPharma Inc presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

What To Hold: 3 Hold-Rated Dividend Stocks SRC, LXK, PDLI

What To Hold: 3 Hold-Rated Dividend Stocks SRC, LXK, PDLI

These 3 dividend stocks are rated a Hold by TheStreet

Buy PDL BioPharma For Strong Upside and High Dividend Yield

Buy PDL BioPharma For Strong Upside and High Dividend Yield

Buy now, and bet on its value

First Week of September 18th Options Trading For PDL BioPharma (PDLI)

First Week of September 18th Options Trading For PDL BioPharma (PDLI)

Investors in PDL BioPharma Inc saw new options begin trading this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PDLI options chain for the new September 18th contracts and identified one put and one call contract of particular interest.

What To Hold: 3 Hold-Rated Dividend Stocks GES, PDLI, GGB

What To Hold: 3 Hold-Rated Dividend Stocks GES, PDLI, GGB

These 3 dividend stocks are rated a Hold by TheStreet

5 Biotech Stocks to Trade for Gains

5 Biotech Stocks to Trade for Gains

Here's a technical look at five biotech stocks that are ready to kick off another leg higher this summer.

3 Hold-Rated Dividend Stocks: GES, TOT, PDLI

3 Hold-Rated Dividend Stocks: GES, TOT, PDLI

These 3 dividend stocks are rated a Hold by TheStreet

3 Hold-Rated Dividend Stocks: PDLI, PKY, PEGI

3 Hold-Rated Dividend Stocks: PDLI, PKY, PEGI

These 3 dividend stocks are rated a Hold by TheStreet

Tomorrow's Ex-Dividends To Watch: ARP, PDLI, TOT

Tomorrow's Ex-Dividends To Watch: ARP, PDLI, TOT

ARP PDLI TOT are going ex-dividend tomorrow, Wednesday, June 03, 2015

'Mad Money' Lightning Round: Sell, Sell, Sell Protein Design Labs

'Mad Money' Lightning Round: Sell, Sell, Sell Protein Design Labs

Cramer says you hold Alcoa for the long term while Hershey is played out.

Jim Cramer's 'Mad Money' Recap: Snap Judgments Will Cost You

Jim Cramer's 'Mad Money' Recap: Snap Judgments Will Cost You

Making money involves tedious homework, not assumptions based on headlines alone, Cramer says.

First Week of PDLI July 17th Options Trading

First Week of PDLI July 17th Options Trading

Investors in PDL BioPharma Inc saw new options begin trading this week, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PDLI options chain for the new July 17th contracts and identified the following put contract of particular interest.

3 Hold-Rated Dividend Stocks: STNG, PBF, PDLI

3 Hold-Rated Dividend Stocks: STNG, PBF, PDLI

These 3 dividend stocks are rated a Hold by TheStreet

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BZH, CAMT, CLR, DIN, EMN, HFBC, NKTR, POL, RDS.A, TMUS, WWWW Downgrades: ANH, BDC, CLD, CTCT, CWEI, GLRE, GOV, HBIO, LNG, MINI, MNR, NCR, ORN, PDLI, PEBO, TKR, VIA, VIAB Initiations: AAC Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: C- (Hold)